Formic Acid

Formic Acid

SCHEMBL29173273

CNc1nc(Nc2ccc(CN3CCOCC3)nc2)c(C(N)=O)nc1-c1cncc2c1ncn2C.O=CO

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 3/20 0.36
▸ CCNC P24863 2/20 0.36
▸ CDK8 P49336 2/20 0.36
▸ EML4 Q9HC35 5/20 0.35
▸ ALK Q9UM73 5/20 0.35
▸ FGFR3 P22607 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ AXL P30530 4/20 0.34
▸ ETV6 P41212 3/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ EPAS1 Q99814 1/20 0.34
▸ RET P07949 5/20 0.33
▸ ROS1 P08922 5/20 0.33
▸ FLT3 P36888 5/20 0.33
▸ PDGFRA P16234 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL30205745 1.00 SYK (0.36) SYKCCNCCDK8EML4ALK
SCHEMBL24943841 0.97 SYK (0.38) SYKCCNCCDK8EML4ALK
SCHEMBL30206281 0.91 HRH3 (0.37) SYKCCNCCDK8FGFR3HRH3
SCHEMBL29173651 0.91 HRH3 (0.37) SYKCCNCCDK8FGFR3HRH3
SCHEMBL30206332 0.89 FGFR3 (0.39) SYKCCNCCDK8FGFR3HRH3
SCHEMBL29173450 0.89 FGFR3 (0.39) SYKCCNCCDK8FGFR3HRH3
SCHEMBL30205579 0.89 SYK (0.44) SYKCCNCCDK8EML4ALK
SCHEMBL24944183 0.89 SYK (0.44) SYKCCNCCDK8EML4ALK
SCHEMBL24944792 0.85 CAMK2D (0.40) SYKCCNCCDK8EML4ALK
SCHEMBL30205550 0.85 CAMK2D (0.40) SYKCCNCCDK8EML4ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN claimed
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN disclosed
Send feedback